Postpoliomyelitis Syndrome Clinical Trial
Official title:
The Impact of an Arm Ergometry Training Programme on Cardiovascular Fitness, Energy Cost of Walking and Fatigue in Prior Polio Patients
The aim of this study is to investigate the effect of upper limb cardiovascular training on fitness, energy cost of walking, fatigue and pain in polio survivors. Polio survivors often have difficulty accessing aerobic forms of exercise due to limitations in mobility, pain associated with walking and fatigue. This can result in becoming physically unfit and places polio survivors at risk of secondary heath problems due to inactivity. A large percentage of polio survivors have lower limb involvement but have strong arms. The participants in this study will exercise at home using simple arm cycles for 8 weeks. They will attend for assessment on two occasions. All exercise will be prescribed by a Physiotherapist and includes measures to ensure safety while exercising at home.
Status | Completed |
Enrollment | 55 |
Est. completion date | September 2013 |
Est. primary completion date | September 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - A confirmed history of Poliomyelitis affecting at least one lower limb, confirmed by the consultant Neurologist, Beaumont Hospital, Dublin, and documented in the medical chart. - Capable of walking for 6 minutes, with or without an aid or appliance (as reported by the patient). - Good upper limb strength, confirmed objectively by Quantitative Muscle Analysis (QMA) (Maximum Voluntary Isometric Contraction (MVIC)). MVIC scores of 7 out of 10 tested upper limb movements must lie above the 5th percentile of the normal range. - Completion of the Physical Activity Readiness Questionnaire (PAR-Q) and cleared by medical practitioner as safe for exercise if indicated. - Aged > 18 and < 75 NOTE: Participants must be resident in Ireland. Exclusion Criteria: - History of unstable cardiac or respiratory conditions - Uncontrolled hypertension - Oxygen dependence - Significant upper limb pain (Visual Analogue Scale > 4 or more than 3 specific sites of pain) - Severe fatigue (Fatigue Severity Scale > 5) - Recent onset of upper limb weakness or severe upper limb weakness (< 5th percentile on more than 3 tested upper limb movements, either reported by the patient or measured using Quantitative Muscle assessment. - Steroid use in last 3 months - Use of medications which may influence cardiovascular testing (Beta-blockers etc) - Pregnant Women |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Ireland | Beaumont Hospital | Dublin |
Lead Sponsor | Collaborator |
---|---|
Royal College of Surgeons, Ireland | Beaumont Hospital, Post Polio Support Group Ireland |
Ireland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Six Minute Arm Test | The Six Minute Arm test is a submaximal cardiovascular fitness test. The American College of Sports Medicine recommend submaximal fitness testing, limited to 6-12 minutes and using either four limb ergometry or an upper limb ergometer in prior polio patients. The 6 Minute Arm Test (Hol et al 2007) is such a submaximal upper limb exercise test, which has been developed and found valid and reliable in spinal cord injury. | Eight weeks | No |
Primary | The Physical Activity Scale for Persons with Physical Disabilities | The Physical Activity Scale for Persons with Physical Disabilities is a subjectively reported survey of activity levels in people with physical disabilities. Preliminary validation has been completed by Washburn et al (2002). | Eight weeks | No |
Secondary | Upper Limb Maximal Voluntary Isometric Contraction | Upper limb strength will be measured to determine suitability for exercise and to measure any training related changes. Maximal voluntary isometric contraction of the upper limbs will be measured using fixed dynamometry with the Quantitative Muscle Analysis system. Shoulder abduction, adduction, elbow flexion and extension and hand grip will be measured. | Eight weeks | No |
Secondary | Body Mass Index and Waist to hip Ratio | Body composition will be assessed using Body Mass Index and Waist to hip ratio will be used to measure risk due to overweight / obesity. | Eight weeks | No |
Secondary | Hand Grip Motor Fatigue | Hand grip motor fatigue will be measured using Quantitative Muscle Analysis. This will be measured pre and post training to provide an indication of changes in motor fatigue occurring with training. | Eight weeks | No |
Secondary | Short Form 36 Version 2 (SF-36 v2) | The SF-36v2 is a tool developed by Ware (www.sf-36.org), which measures health status. It has been used previously in polio survivors (Vasiliadis et al 2002, Gonzales et al 2006) | Eight weeks | No |
Secondary | Short Form McGill Pain Questionnaire version 2 (SF-MPQ-2) | Pain will be assessed using the SF-MPQ-2. The SF-MPQ-2 questionnaire is a well-developed tool for quantitative assessment of pain (Dworkin et al 2009). | Eight weeks | No |
Secondary | Physiological Cost Index | The Physiological Cost Index is a measure, which aims to estimate energy cost of walking, using walking speed and change in heart rate from baseline. | Eight weeks | No |
Secondary | The Fatigue Severity Scale | The Fatigue Severity Scale is a commonly used questionnaire used to assess subjective fatigue | Eight weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05663008 -
Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis
|
||
Completed |
NCT00001185 -
Study of "Post-Polio Syndrome"
|
N/A | |
Recruiting |
NCT06320444 -
Non-invasive Spinal, Cortical, and Sensorimotor Biomarkers in Motor Neurone Disease
|
||
Completed |
NCT00004553 -
Electromyography to Diagnose Neuromuscular Disorders
|
N/A | |
Terminated |
NCT00067496 -
Modafinil to Treat Fatigue in Post-Polio Syndrome
|
Phase 3 | |
Withdrawn |
NCT01549847 -
A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome
|
Phase 3 |